Cipla To Buy Foreign Partners To Become Local Company In Key Markets
This article was originally published in PharmAsia News
Executive Summary
Cipla plans to turn more of its foreign partnerships into acquisitions, particularly in emerging markets, as it follows a new strategy for becoming even more of a global player in the drug industry.